Summary

The global organ transplant diagnostics market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include the growing prevalence of chronic diseases, the increase in the number of organ transplantation surgeries, and the adoption of advanced technology in the field of transplant diagnostics, which are impelling the growth of the market. Organ transplantation is a medical technique in which an organ is removed from one body and placed in a recipient’s body to substitute a damaged or missing organ. The other factors supporting the market’s growth are, increasing government initiatives for spreading awareness, the rising geriatric population, the rising incidence of organ failure, high demand for molecular diagnostic tests, the surging investment and expenditure in healthcare and diagnostics, growing number of the organ transplant procedure, growing launch of programs & new product development in organ transplant diagnosis, and rise in research and development activities.
Rising Incidences of Chronic diseases
The increasing occurrence of chronic diseases, such as diabetes, cardiovascular diseases, and others, across the globe, are bolstering the growth of the market. This is attributed to the increased risk of organ failure among patients suffering from chronic diseases. According to the WHO, Cardiovascular diseases (CVDs) are the leading cause of death worldwide, taking approximately 17.9 million lives each year. Also, the geriatric population is more prone to organ malfunction, especially the liver, heart, and kidney, thus, in turn, driving the growth of the market. As per the United States Government Information on Organ Donation and Transplantation, in 2019, 63 % of those who had organ transplants were aged 50 or older, and 21% of overall organ transplant individuals were aged 65 and above.
Increasing Awareness and Increase in the Number of Organ Transplantation Surgeries
Over the past few years, people are becoming more aware of organ transplantation, which is augmenting the growth of the market. Owing to the awareness among the masses, people are going for organ transplantation surgeries, which is fueling the growth of the market. Various initiatives are taken by the government and non-government organizations to make people aware of organ transplantation. Moreover, the rise in number of organ transplantation surgeries is fueling the growth of the market. Owing to the increase in the number of patients with organ failure, the demand for transplant procedures is rising, which is facilitating the growth of the market. According to Health Resources and Services Administration, in 2019, about 112,568 people in the U.S. required organ transplantation.
Market Segmentation
The global organ transplant diagnostics market is segmented into component, transplant type, technology, application, end-user, and company. Based on components, the market is divided into kits & assays, consumables, and services. Based on transplant type, the market is divided into solid organ transplants and stem cell transplants. Based on technology, the market is segmented into molecular technologies, serology, flow cytometry, and others. Based on application, the market is divided into clinical diagnostics and translational research. Based on end-user, the market is divided into hospitals & transplant centers, academic & research institutions, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the rise in the number of organ transplantation surgeries in the country.
Market Players
Illumina, Inc., Thermo Fischer Scientific, Inc., Abbott Laboratories, Inc., Quest Diagnostics, Inc., F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Laboratory Corporation of America Holdings, bioMérieux S.A., CareDx, Inc, and Immucor, Inc. are some of the leading companies operating in the market.
Report Scope:
In this report, global organ transplant diagnostics market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• Organ Transplant Diagnostics Market, By Component:
o Kits & Assays
o Consumables
o Services
• Organ Transplant Diagnostics Market, By Transplant Type:
o Solid Organ Transplant
o Stem Cell Transplant
• Organ Transplant Diagnostics Market, By Technology:
o Molecular Technologies
o Serology
o Flow Cytometry
o Others
• Organ Transplant Diagnostics Market, By Application:
o Clinical Diagnostics
o Translational Research
• Organ Transplant Diagnostics Market, By End User:
o Hospitals & Transplant Centers
o Academic & Research Institutions
o Others
• Organ Transplant Diagnostics Market, By Region:
o North America
 United States
 Canada
 Mexico
o Asia-Pacific
 China
 India
 Japan
 Australia
 South Korea
o Europe & CIS
 Germany
 France
 United Kingdom
 Spain
 Italy
o South America
 Brazil
 Argentina
 Colombia
o Middle East & Africa
 South Africa
 Saudi Arabia
 UAE
 Turkey
 Egypt
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Global Organ Transplant Diagnostics Market
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Organ Transplant Diagnostics Market
5. Voice of Customer
6. Global Organ Transplant Diagnostics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Component (Kits & Assays, Consumables, Services)
6.2.2. By Transplant Type (Solid Organ Transplant v/s Stem Cell Transplant)
6.2.3. By Technology (Molecular Technologies, Serology, Flow Cytometry, Others)
6.2.4. By Application (Clinical Diagnostics v/s Translational Research)
6.2.5. By End User (Hospitals & Transplant Centers, Academic & Research Institutions, Others)
6.2.6. By Company (2021)
6.2.7. By Region
6.3. Market Map
7. North America Organ Transplant Diagnostics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Component
7.2.2. By Transplant Type
7.2.3. By Technology
7.2.4. By Application
7.2.5. By End User
7.2.6. By Country
7.3. North America: Country Analysis
7.3.1. United States Organ Transplant Diagnostics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Component
7.3.1.2.2. By Transplant Type
7.3.1.2.3. By Technology
7.3.1.2.4. By Application
7.3.1.2.5. By End User
7.3.2. Canada Organ Transplant Diagnostics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Component
7.3.2.2.2. By Transplant Type
7.3.2.2.3. By Technology
7.3.2.2.4. By Application
7.3.2.2.5. By End User
7.3.3. Mexico Organ Transplant Diagnostics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Component
7.3.3.2.2. By Transplant Type
7.3.3.2.3. By Technology
7.3.3.2.4. By Application
7.3.3.2.5. By End User
8. Europe Organ Transplant Diagnostics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Component
8.2.2. By Transplant Type
8.2.3. By Technology
8.2.4. By Application
8.2.5. By End User
8.2.6. By Country
8.3. Europe: Country Analysis
8.3.1. France Organ Transplant Diagnostics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Component
8.3.1.2.2. By Transplant Type
8.3.1.2.3. By Technology
8.3.1.2.4. By Application
8.3.1.2.5. By End User
8.3.2. Germany Organ Transplant Diagnostics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Component
8.3.2.2.2. By Transplant Type
8.3.2.2.3. By Technology
8.3.2.2.4. By Application
8.3.2.2.5. By End User
8.3.3. United Kingdom Organ Transplant Diagnostics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Component
8.3.3.2.2. By Transplant Type
8.3.3.2.3. By Technology
8.3.3.2.4. By Application
8.3.3.2.5. By End User
8.3.4. Italy Organ Transplant Diagnostics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Component
8.3.4.2.2. By Transplant Type
8.3.4.2.3. By Technology
8.3.4.2.4. By Application
8.3.4.2.5. By End User
8.3.5. Spain Organ Transplant Diagnostics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Component
8.3.5.2.2. By Transplant Type
8.3.5.2.3. By Technology
8.3.5.2.4. By Application
8.3.5.2.5. By End User
9. Asia-Pacific Organ Transplant Diagnostics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Component
9.2.2. By Transplant Type
9.2.3. By Technology
9.2.4. By Application
9.2.5. By End User
9.2.6. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Organ Transplant Diagnostics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Component
9.3.1.2.2. By Transplant Type
9.3.1.2.3. By Technology
9.3.1.2.4. By Application
9.3.1.2.5. By End User
9.3.2. India Organ Transplant Diagnostics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Component
9.3.2.2.2. By Transplant Type
9.3.2.2.3. By Technology
9.3.2.2.4. By Application
9.3.2.2.5. By End User
9.3.3. Japan Organ Transplant Diagnostics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Component
9.3.3.2.2. By Transplant Type
9.3.3.2.3. By Technology
9.3.3.2.4. By Application
9.3.3.2.5. By End User
9.3.4. South Korea Organ Transplant Diagnostics Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Component
9.3.4.2.2. By Transplant Type
9.3.4.2.3. By Technology
9.3.4.2.4. By Application
9.3.4.2.5. By End User
9.3.5. Australia Organ Transplant Diagnostics Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Component
9.3.5.2.2. By Transplant Type
9.3.5.2.3. By Technology
9.3.5.2.4. By Application
9.3.5.2.5. By End User
10. South America Organ Transplant Diagnostics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Component
10.2.2. By Transplant Type
10.2.3. By Technology
10.2.4. By Application
10.2.5. By End User
10.2.6. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Organ Transplant Diagnostics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Component
10.3.1.2.2. By Transplant Type
10.3.1.2.3. By Technology
10.3.1.2.4. By Application
10.3.1.2.5. By End User
10.3.2. Argentina Organ Transplant Diagnostics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Component
10.3.2.2.2. By Transplant Type
10.3.2.2.3. By Technology
10.3.2.2.4. By Application
10.3.2.2.5. By End User
10.3.3. Colombia Organ Transplant Diagnostics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Component
10.3.3.2.2. By Transplant Type
10.3.3.2.3. By Technology
10.3.3.2.4. By Application
10.3.3.2.5. By End User
11. Middle East and Africa Organ Transplant Diagnostics Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Component
11.2.2. By Transplant Type
11.2.3. By Technology
11.2.4. By Application
11.2.5. By End User
11.2.6. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Organ Transplant Diagnostics Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Component
11.3.1.2.2. By Transplant Type
11.3.1.2.3. By Technology
11.3.1.2.4. By Application
11.3.1.2.5. By End User
11.3.2. Saudi Arabia Organ Transplant Diagnostics Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Component
11.3.2.2.2. By Transplant Type
11.3.2.2.3. By Technology
11.3.2.2.4. By Application
11.3.2.2.5. By End User
11.3.3. UAE Organ Transplant Diagnostics Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Component
11.3.3.2.2. By Transplant Type
11.3.3.2.3. By Technology
11.3.3.2.4. By Application
11.3.3.2.5. By End User
11.3.4. Turkey Organ Transplant Diagnostics Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Component
11.3.4.2.2. By Transplant Type
11.3.4.2.3. By Technology
11.3.4.2.4. By Application
11.3.4.2.5. By End User
11.3.5. Egypt Organ Transplant Diagnostics Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Component
11.3.5.2.2. By Transplant Type
11.3.5.2.3. By Technology
11.3.5.2.4. By Application
11.3.5.2.5. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Illumina, Inc.
14.2. Thermo Fischer Scientific, Inc.
14.3. Abbott Laboratories, Inc.
14.4. Quest Diagnostics, Inc.
14.5. F. Hoffmann-La Roche AG
14.6. Bio-Rad Laboratories, Inc.
14.7. Laboratory Corporation of America Holdings
14.8. bioMérieux S.A.
14.9. CareDx, Inc
14.10. Immucor, Inc.
15. Strategic Recommendations